REQUEST A DEMO
Total
USD $0.00
Search more companies

Ibio Company Limited (Thailand)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Ibio Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Ibio Company Limited is a company based in Thailand, with its head office in Bangkok , Special Governed District of. The enterprise currently operates in the Medicinal and Botanical Manufacturing sector. Ibio Company Limited was incorporated on May 22, 2026. The total number of employees is currently 80 (estimated). The latest financial highlights indicate a net sales revenue increase of 0.29% in 2024. Its’ total assets recorded a growth of 30.92%. In 2024, Ibio Company Limited’s net profit margin increased by 0.12%.

Headquarters
589/84 Bang Na-Trad Road
Bangkok , Special Governed District of; Central Thailand; Postal Code: 10260

Contact Details: Purchase the Ibio Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Ibio Company Limited report to view the information.
Outstanding Shares:
Purchase the Ibio Company Limited report to view the information.
Financial Auditors:
Purchase the Ibio Company Limited report to view the information.
Incorporation Date:
May 22, 2026
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
33%
Company Performance
Financial values in the chart are available after Ibio Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
0.29%
Total Operating Revenue
0.73%
Operating Profit
13%
EBITDA
13%
Net Profit/Loss for the Period
5.74%
Total Assets
30.92%
Total Equity
2.17%
Operating Profit Margin
0.46%
Net Profit Margin
0.12%
Return on Equity (ROE)
0.5%
Debt / Equity
64.33%
Quick Ratio
0.03%
Cash Ratio
0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?